Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome. (Q51471902)
Jump to navigation
Jump to search
scientific article published on 4 May 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome. |
scientific article published on 4 May 2007 |
Statements
Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome. (English)
1 reference
Robert S Rosenson
1 reference
David A Wolff
1 reference
Anna L Huskin
1 reference
Irene B Helenowski
1 reference
Alfred W Rademaker
1 reference
4 May 2007
1 reference
30
1 reference
8
1 reference
1945-1951
1 reference